Parainfluenza virus type 3

Common Name(s)

Parainfluenza virus type 3

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Parainfluenza virus type 3" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Parainfluenza virus type 3" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Parainfluenza virus type 3" returned 107 free, full-text research articles on human participants. First 3 results:

Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.
 

Author(s): Bo Liang, Shirin Munir, Emerito Amaro-Carambot, Sonja Surman, Natalie Mackow, Lijuan Yang, Ursula J Buchholz, Peter L Collins, Anne Schaap-Nutt

Journal: J. Virol.. 2014 Apr;88(8):4237-50.

 

A recombinant chimeric bovine/human parainfluenza type 3 virus (rB/HPIV3) vector expressing the respiratory syncytial virus (RSV) fusion F glycoprotein previously exhibited disappointing levels of RSV F immunogenicity and genetic stability in children (D. Bernstein et al., Pediatr. ...

Last Updated: 27 Mar 2014

Go To URL
Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children.
 

Author(s): Janet A Englund, Ruth A Karron, Coleen K Cunningham, Philip Larussa, Ann Melvin, Ram Yogev, Ed Handelsman, George K Siberry, Bhavanji Thumar, Elizabeth Schappell, Catherine V Bull, Helen Y Chu, Anne Schaap-Nutt, Ursula Buchholz, Peter L Collins, Alexander C Schmidt,

Journal: Vaccine. 2013 Nov;31(48):5706-12.

 

Human parainfluenza virus type 3 (HPIV3) is a common cause of upper and lower respiratory tract illness in infants and young children. Live-attenuated cold-adapted HPIV3 vaccines have been evaluated in infants but a suitable interval for administration of a second dose of vaccine ...

Last Updated: 4 Nov 2013

Go To URL
An amino acid of human parainfluenza virus type 3 nucleoprotein is critical for template function and cytoplasmic inclusion body formation.
 

Author(s): Shengwei Zhang, Longyun Chen, Guangyuan Zhang, Qin Yan, Xiaodan Yang, Binbin Ding, Qiaopeng Tang, Shengjun Sun, Zhulong Hu, Mingzhou Chen

Journal: J. Virol.. 2013 Nov;87(22):12457-70.

 

The nucleoprotein (N) and phosphoprotein (P) interaction of nonsegmented negative-strand RNA viruses is essential for viral replication; this includes N⁰-P (N⁰, free of RNA) interaction and the interaction of N-RNA with P. The precise site(s) within N that mediates the N-P interaction ...

Last Updated: 18 Oct 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Parainfluenza virus type 3" returned 1 free, full-text review articles on human participants. First 3 results:

Medical burden of respiratory syncytial virus and parainfluenza virus type 3 infection among US children. Implications for design of vaccine trials.
 

Author(s): Min-Shi Lee, Robert E Walker, Paul M Mendelman

Journal: Hum Vaccin. ;1(1):6-11.

 

Respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) are two leading causes of lower respiratory illness (LRI) in infants. Many efforts have been directed to develop vaccines against these two viruses. Licensure of new vaccines includes three phases of clinical ...

Last Updated: 13 Oct 2006

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

There are currently no open clinical trials for this condition.